Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1995 1
1996 1
1997 2
1999 1
2002 1
2008 4
2009 2
2010 4
2011 3
2012 2
2014 1
2015 4
2016 2
2017 3
2018 4
2019 4
2020 1
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
The Authors Reply.
Desideri S, Onions KL, Butler MJ, Michel CC, Satchell SC, Salmon AHJ, Foster RR. Desideri S, et al. Kidney Int. 2018 Jul;94(1):220. doi: 10.1016/j.kint.2018.04.013. Kidney Int. 2018. PMID: 29933849 Free article. No abstract available.
Non-hormonal therapy of premenstrual syndrome.
Martignoni E, Desideri S, Sances G, Corengia E. Martignoni E, et al. Among authors: desideri s. Cephalalgia. 1997 Dec;17 Suppl 20:20-4. doi: 10.1177/0333102497017S2007. Cephalalgia. 1997. PMID: 9496773 Review. No abstract available.
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma.
Strowd R, Ellingson B, Raymond C, Yao J, Wen PY, Ahluwalia M, Piotrowski A, Desai A, Clarke JL, Lieberman FS, Desideri S, Nabors LB, Ye X, Grossman S. Strowd R, et al. Among authors: desideri s. J Neurooncol. 2023 Oct;165(1):101-112. doi: 10.1007/s11060-023-04456-7. Epub 2023 Oct 21. J Neurooncol. 2023. PMID: 37864646 Free PMC article. Clinical Trial.
Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma.
Blakeley JO, Grossman SA, Chi AS, Mikkelsen T, Rosenfeld MR, Ahluwalia MS, Nabors LB, Eichler A, Ribas IG, Desideri S, Ye X; Adult Brain Tumor Consortium. Blakeley JO, et al. Among authors: desideri s. Clin Cancer Res. 2019 Jan 1;25(1):73-79. doi: 10.1158/1078-0432.CCR-18-0110. Epub 2018 Aug 21. Clin Cancer Res. 2019. PMID: 30131387 Free PMC article. Clinical Trial.
VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy.
Onions KL, Gamez M, Buckner NR, Baker SL, Betteridge KB, Desideri S, Dallyn BP, Ramnath RD, Neal CR, Farmer LK, Mathieson PW, Gnudi L, Alitalo K, Bates DO, Salmon AHJ, Welsh GI, Satchell SC, Foster RR. Onions KL, et al. Among authors: desideri s. Diabetes. 2019 Jan;68(1):172-187. doi: 10.2337/db18-0045. Epub 2018 Nov 2. Diabetes. 2019. PMID: 30389746
Rituximab monotherapy for patients with recurrent primary CNS lymphoma.
Batchelor TT, Grossman SA, Mikkelsen T, Ye X, Desideri S, Lesser GJ. Batchelor TT, et al. Among authors: desideri s. Neurology. 2011 Mar 8;76(10):929-30. doi: 10.1212/WNL.0b013e31820f2d94. Neurology. 2011. PMID: 21383331 Free PMC article. Clinical Trial. No abstract available.
Response rate and molecular correlates to encorafenib and binimetinib in BRAF-V600E mutant high-grade glioma.
Schreck KC, Strowd RE, Nabors LB, Ellingson BM, Chang M, Tan SK, Abdullaev Z, Turakulov R, Aldape K, Danda N, Desideri S, Fisher J, Iacoboni M, Surakus T, Rudek MA, Bettegowda C, Grossman SA, Ye X. Schreck KC, et al. Among authors: desideri s. Clin Cancer Res. 2024 Mar 6. doi: 10.1158/1078-0432.CCR-23-3241. Online ahead of print. Clin Cancer Res. 2024. PMID: 38446982
42 results